Buprenorphine and Integrated HIV Care Evaluation

Status unconfirmed · Phase 4

Conditions studied: Opioid-Related Disorders, HIV Infections, AIDS

In brief

The purpose of this study is to assess the feasibility, cost and effectiveness of interventions designed to integrate buprenorphine treatment for opioid dependence into HIV primary care in ten HIV care centers in the U.S.

Key facts

Study ID

NCT00124358

Run by

The New York Academy of Medicine

People needed

1350

Starts

2005-08-01

Expected to finish

2008-12-01

Last updated by the study team

2007-03-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV-infected
• Clinical diagnosis of opioid dependence
• Fluent in English or Spanish
• 18 years or older

You may not qualify if…

• Liver function tests (transaminase only) at five times or higher than normal level;
• Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition (DSM-IV) criteria for benzodiazepine abuse or dependence within the past 6 months;
• DSM-IV criteria for alcohol dependence within the past 6 months;
• Actively suicidal;
• Psychiatric impairment that impedes ability to consent (dementia, delusional, actively psychotic);
• Methadone dose exceeding levels allowing for safe transition to buprenorphine;
• Pregnant women and women actively trying to become pregnant;
• Clinical judgment of local site principal investigator that patient is inappropriate

Where it is running

• El Rio Santa Cruz Neighborhood Health Center — Tucson, Arizona, United States (enrolling)
• Organization to Achieve Solutions in Substance Abuse — Oakland, California, United States (enrolling)
• University of California San Francisco — San Francisco, California, United States (enrolling)
• Yale University School of Medicine AIDS Program — New Haven, Connecticut, United States (enrolling)
• University of Miami School of Medicine — Miami, Florida, United States (enrolling)
• The CORE Center — Chicago, Illinois, United States (enrolling)
• Johns Hopkins University — Baltimore, Maryland, United States (enrolling)
• Montefiore Medical Center — New York, New York, United States (enrolling)
• Oregon Health & Science University — Portland, Oregon, United States (enrolling)
• The Miriam Hospital — Providence, Rhode Island, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.